✦ LIBER ✦

A pilot placebo-controlled study of chronic m-CPP administration in Alzheimer's disease

✍ Scribed by Brian A. Lawlor; Trey Sunderland; Alan M. Mellow; Susan E. Molchan; Rick Martinez; Dennis L. Murphy

Book ID: 118855060
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 641 KB
Volume: 30
Category: Article
ISSN: 0006-3223
DOI: 10.1016/0006-3223(91)90167-k

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A pilot placebo-controlled study of traz

A pilot placebo-controlled study of trazodone and buspirone in alzheimer's disease

✍ Dr. Brian A. Lawlor; Jeanne Radcliffe; Susan E. Molchan; Rick A. Martinez; James 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

The pharmacological management of behavioural symptoms in Alzheimer's disease is limited by the dearth of effective agents in this area. The purpose of this study was to determine whether trazodone or buspirone are helpful in the treatment of behavioural disturbance in AD. Ten patients meeting NINCD

Double-blind placebo-controlled study of

Double-blind placebo-controlled study of velnacrine in Alzheimer's disease

✍ Frank P. Zemlan; Michael Keys; Ralph W. Richter; Richard L. Strub 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 672 KB

A double-blind, placebo controlled, mult

A double-blind, placebo controlled, multicentre study of tacrine for alzheimer's disease

✍ Philip C. Wood; Professor C. Mark Castleden 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

The present study was designed to determine whether oral tacrine (tetrahydroaminoacridine, THA) improves the symptoms of patients with mild to moderate Alzheimer's disease. The study was a multicentre, randomized doubleblind, placebo controlled, parallel group study with individual determination of

Efficacy of a Vitamin/Nutriceutical Form

Efficacy of a Vitamin/Nutriceutical Formulation for Moderate-stage to Later-stage Alzheimer's disease: A Placebo-controlled Pilot Study

✍ Remington, R.; Chan, A.; Paskavitz, J.; Shea, T. B. 📂 Article 📅 2008 🏛 SAGE Publications 🌐 English ⚖ 255 KB

Galantamine alleviates caregiver burden

Galantamine alleviates caregiver burden in Alzheimer's disease: A 6-month placebo-controlled study

✍ Wilcock, Gordon K.; Lilienfeld, Sean 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 168 KB

A 24-week, double-blind, placebo-control

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease—pilot study

✍ Vee. P. Prasher; Adam Huxley; M. S. Haque 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

## Abstract ## Background Donepezil Hydrochloride (Aricept) is a selective anticholinesterase inhibitor developed for the treatment of Alzheimer's disease (AD). This study investigated the safety and efficacy of the drug to treat Down syndrome (DS) adults with mild to moderate AD. ## Method This